Anondita Medicare Peer Comparison
NSE: ANONDITA
₹1,071.50
As on 16-Oct-2026IST
Market cap
₹2,041 Cr
Revenue (TTM)
₹137 Cr
P/E Ratio
61
P/B Ratio
9.3
Div. Yield
0 %
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
2,041 | 50,216 | 7,342 | 1,015 | 62 |
Revenue (₹ Cr) |
137 | 6,725 | 7,229 | 287 | 21 |
Net Profit (₹ Cr) |
34.30 | 1,128.79 | 210.43 | 28.67 | 3.24 |
Net Margin (%) |
24.81 | 16.02 | 2.88 | 9.68 | 15.18 |
RoE (%) |
41.24 | 11.51 | 11.02 | 9.14 | 19.12 |
Price to Earnings |
61.01 | 44.49 | 34.88 | 32.86 | 19.00 |
Price-To-Book |
9.26 | 4.72 | 3.67 | 4.14 | 3.31 |
Income Statement (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Operating Revenue
|
137.42 | 6,430.65 | 6,892.47 | 277.86 | -- |
|
Total Income
|
138.26 | 6,746.98 | 6,963.79 | 286.40 | -- |
|
Total Expenditure
|
86.73 | 4,801.11 | 6,268.09 | 233.97 | -- |
|
EBITDA
|
50.68 | 1,629.54 | 624.38 | 43.89 | -- |
|
Depreciation
|
1.08 | 423.67 | 282.87 | 15.88 | -- |
|
EBIT
|
49.60 | 1,205.88 | 341.51 | 28.02 | -- |
|
Interest
|
3.56 | 33.28 | 137.50 | 1.86 | -- |
|
Other Income
|
0.84 | 316.33 | 71.32 | 8.55 | -- |
|
Exceptional Items
|
-- | -24.35 | -- | -5.78 | -- |
|
Profit before Tax
|
46.89 | 1,464.58 | 275.33 | 28.93 | -- |
|
Provision for Tax
|
12.59 | 437.26 | 55.72 | 2.50 | -- |
|
Profit after Tax
|
34.30 | 1,027.32 | 219.61 | 26.43 | -- |
Liabilities (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
129.24 | 10,357.95 | 1,975.36 | 243.32 | -- |
|
Minority Interest
|
2.03 | -- | -0.71 | 0.79 | -- |
|
Non-Current Liabilities
|
25.98 | 482.17 | 1,225.00 | 14.83 | -- |
|
Current Liabilities
|
27.58 | 1,608.40 | 763.90 | 30.79 | -- |
|
Total Liabilities
|
184.83 | 12,448.52 | 4,084.80 | 300.10 | -- |
Assets (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
86.31 | 4,921.74 | 1,820.29 | 101.01 | -- |
|
Current Assets
|
98.52 | 7,526.79 | 2,143.26 | 188.72 | -- |
|
Total Assets
|
184.83 | 12,448.52 | 4,084.80 | 300.10 | -- |
|
Total Debt*
|
33.60 | 243.36 | 0.00 | 0.00 | -- |
|
Net Current Assets
|
70.94 | 5,918.38 | 1,379.36 | 157.93 | -- |
|
Contingent Liabilities
|
5.26 | 10.12 | 14.06 | -- | -- |
Cashflow (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
10.64 | 1,031.39 | 495.58 | -5.00 | -- |
|
Cash Flow from Investing Activities
|
-62.70 | 137.73 | -127.72 | -79.58 | -- |
|
Cash from Financing Activities
|
61.28 | -416.97 | -255.51 | -17.75 | -- |
|
Net Cash Inflow / Outflow
|
9.22 | 752.14 | 112.36 | -102.33 | -- |
Ratios
Profitability Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
ROCE (%)
|
44.38 | 14.96 | 22.22 | 13.29 | -- |
|
ROE (%)
|
41.24 | 10.56 | 11.93 | 11.95 | -- |
|
ROA (%)
|
26.21 | 8.70 | 6.00 | 9.31 | -- |
|
EBIT Margin (%)
|
37.50 | 30.26 | 10.09 | 18.87 | -- |
|
Net Margin (%)
|
24.81 | 15.23 | 3.15 | 9.23 | -- |
|
Cash Profit Margin (%)
|
25.74 | 22.56 | 7.19 | 15.23 | -- |
Growth Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
78.48 | 14.50 | 12.33 | 16.21 | -- |
|
EBIT Growth (%)
|
99.55 | 31.25 | 26.01 | 14.03 | -- |
|
Net Profit Growth (%)
|
107.80 | 47.07 | 46.18 | 4.16 | -- |
|
EPS Growth (%)
|
54.78 | 47.07 | 45.68 | -8.79 | -- |
|
Book Value Growth (%)
|
248.40 | 12.70 | 14.76 | 14.31 | -- |
Valuation Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Price / Earnings
|
35.45 | 27.22 | 45.79 | 29.86 | -- |
|
Price / Book Value
|
9.17 | 2.71 | 5.11 | 3.67 | -- |
|
Dividend Yield (%)
|
0.00 | 1.18 | 0.00 | 0.00 | -- |
|
EV/EBITDA
|
23.59 | 12.77 | 13.79 | 16.32 | -- |
|
Market Cap (₹ Cr)
|
1,191.46 | 27,964.97 | 10,057.49 | 865.33 | -- |
Solvency Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.26 | 0.02 | 0.00 | 0.00 | -- |
|
Short term debt to equity ratio
|
0.05 | -- | -- | -- | -- |
|
Current Ratio
|
3.57 | 4.68 | 2.81 | 6.13 | -- |
|
Quick Ratio
|
2.82 | 3.60 | 1.00 | 5.42 | -- |
|
Interest Coverage
|
14.19 | 45.01 | 3.00 | 16.57 | -- |
Operating Efficiency Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
37.74 | 29.41 | 0.39 | 16.39 | -- |
|
Asset Turnover
|
1.05 | 0.54 | 1.91 | 0.98 | -- |
|
Receivable days
|
104.40 | 96.72 | 1.05 | 54.00 | -- |
|
Inventory Days
|
45.49 | 97.32 | 71.25 | 26.54 | -- |
|
Payable days
|
35.99 | 134.60 | 21.75 | 94.91 | -- |
|
Cash Conversion Cycle
|
113.90 | 59.43 | 50.55 | -14.37 | -- |